Our Articles

Explore our thought leadership article library, where you can find a wealth of insights on regulatory intelligence, industry updates, and the latest pharmaceutical and biotechnology developments.

Becky Murphy Becky Murphy

Australian R&D Cashback & Early Development Activities

With demand for improved healthcare increasing globally, Australia is continuing to emerge as an attractive destination for the development of new and improved drugs and medical devices, driven by excellent research capabilities, a favourable Therapeutic Goods Administration (TGA) regime and an attractive Research and Development Tax Incentive (RDTI) regime.

Read More
Tom Allport Tom Allport

Clinical Trial Regulation: A New Chapter for EU Clinical Trials

We are thrilled to announce the release of our new whitepaper, in collaboration with FGK, "Clinical Trial Regulation: A New Chapter for EU Clinical Trials", authored by Senior Consultant, Amy Cooke, Principal Consultant, Dr Maria Beatrice Panico, and Director of Regulatory Affairs at FGK, Dr Uwe Kramer.

Read More
Tom Allport Tom Allport

The Importance of Regulatory Strategy

Getting a new drug to the patient involves numerous stakeholders that are part of a multi-faceted regulatory framework. This framework has evolved over time and proceeds from drug discovery to development to regulatory evaluation.

Read More